Cures 2.0 legislation  was introduced on Capitol Hill in 2021 included a provision (Section 408) that would establish coverage for pharmacogenetic consultations delivered by qualified clinical pharmacists. Cures 2.0 enjoyed widespread bi-partisan support, but ultimately Congress failed to pass the bill into law.

In June, 2024, Rep. DeGette wrote to ACCP indicating her intention to reintroduce Cures 2.0, and she invited ACCP to submit recommendations on the draft proposal.

Now we need your help.

Members of Congress need to hear directly from clinical pharmacists about the importance of pharmacogenomic testing, and the emerging world of precision medicine, and why it is essential that the PGx consultation provision is included in the new Cures 2.0 language.

Contacting the offices of your elected officials is simple. We have prepared a letter for you to review and edit. Simply follow the instructions to send this message to Capitol Hill.

Please take the time to personalize the letter by providing additional information about your practice and the patients you care for. Pharmacists across the country are working under extraordinary circumstances to improve patient outcomes through team-based models of care. As policymakers assess the strengths and weaknesses of our nation's healthcare infrastructure, it is vital they hear about the ongoing work of clinical pharmacists.

Thank you for your participation in this important advocacy effort. Please also sign up for the Get the Medications Right Institute to stay on top of exciting developments related to our work in Washington, DC.